BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12069370)

  • 1. Nedocromil sodium ophthalmic solution 2% twice daily in patients with allergic conjunctivitis.
    Tauber J;
    Adv Ther; 2002; 19(2):73-84. PubMed ID: 12069370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twice-daily and once-daily nedocromil sodium 2% ophthalmic solution for the treatment of seasonal allergic conjunctivitis.
    Alexander M; Allegro S; Hicks A
    Adv Ther; 2002; 19(1):9-16. PubMed ID: 12008862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and acceptability of nedocromil sodium 2% and olopatadine hydrochloride 0.1% in perennial allergic conjunctivitis.
    Alexander M; Allegro S; Hicks A
    Adv Ther; 2000; 17(3):140-7. PubMed ID: 11183450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplementation of fexofenadine therapy with nedocromil sodium 2% ophthalmic solution to treat ocular symptoms of seasonal allergic conjunctivitis.
    Alexander M; Patel P; Allegro S; Hicks A
    Clin Exp Ophthalmol; 2003 Jun; 31(3):206-12. PubMed ID: 12786770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nedocromil sodium 2% ophthalmic solution for the treatment of ragweed pollen seasonal allergic conjunctivitis.
    Blumenthal MN; Schwartz RH; Kaiser H
    Ocul Immunol Inflamm; 2000 Sep; 8(3):159-67. PubMed ID: 11120577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nedocromil sodium in golfers with seasonal allergic conjunctivitis.
    Alexander M; Allegro S; Hicks A
    Adv Ther; 2001; 18(5):195-204. PubMed ID: 11783456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nedocromil sodium as a topical treatment of allergic conjunctivitis due to grasses].
    Pacor ML; Biasi D; Maleknia T; Carletto A; Lunardi C
    Recenti Prog Med; 1996 May; 87(5):215-7. PubMed ID: 8767757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of nedocromil sodium 2% ophthalmic solution b.i.d. in the treatment of ragweed seasonal allergic conjunctivitis.
    Melamed J; Schwartz RH; Blumenthal MN; Zeitz HJ
    Allergy Asthma Proc; 2000; 21(4):235-9. PubMed ID: 10951891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nedocromil sodium 2% eye drops for twice-daily treatment of seasonal allergic conjunctivitis: a Swedish multicentre placebo-controlled study in children allergic to birch pollen.
    Möller C; Berg IM; Berg T; Kjellman M; Strömberg L
    Clin Exp Allergy; 1994 Sep; 24(9):884-7. PubMed ID: 7812890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of nedocromil sodium ophthalmic solution in the treatment of seasonal allergic conjunctivitis.
    Blumenthal M; Casale T; Dockhorn R; Jarmoszuk I; Kaiser H; Smith R; Zeitz HJ
    Am J Ophthalmol; 1992 Jan; 113(1):56-63. PubMed ID: 1309410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two mast cell stabilizers, pemirolast potassium 0.1% and nedocromil sodium 2%, in the treatment of seasonal allergic conjunctivitis: a comparative study.
    Shulman DG
    Adv Ther; 2003; 20(1):31-40. PubMed ID: 12772816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of nedocromil sodium in perennial allergic conjunctivitis].
    Pacor ML; Biasi D; Carletto A; Corrocher R; Lunardi C
    Recenti Prog Med; 1998 Oct; 89(10):501-3. PubMed ID: 9842252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of emedastine 0.05% or nedocromil sodium 2% eye drops and placebo in controlling local reactions in subjects with allergic conjunctivitis.
    Orfeo V; Vardaro A; Lena P; Mensitieri I; Tracey M; De Marco R
    Eur J Ophthalmol; 2002; 12(4):262-6. PubMed ID: 12219994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with Tilavist: an overview of efficacy and safety.
    Kjellman NI; Stevens MT
    Allergy; 1995; 50(21 Suppl):14-22; discussion 34-8. PubMed ID: 7785746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of topical nedocromil sodium and oral terfenadine for the treatment of seasonal allergic conjunctivitis.
    Alexander M; Rosen LJ; Yang WH
    Clin Ther; 1999 Nov; 21(11):1900-7. PubMed ID: 10890262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model.
    Butrus S; Greiner JV; Discepola M; Finegold I
    Clin Ther; 2000 Dec; 22(12):1462-72. PubMed ID: 11192137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial.
    Crampton HJ
    Clin Ther; 2003 Jul; 25(7):1975-87. PubMed ID: 12946545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placebo-controlled comparison of ketotifen fumarate and nedocromil sodium ophthalmic solutions for the prevention of ocular itching with the conjunctival allergen challenge model.
    Greiner JV; Minno G
    Clin Ther; 2003 Jul; 25(7):1988-2005. PubMed ID: 12946546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of nedocromil sodium 2% ophthalmic solution for the treatment of seasonal allergic conjunctivitis.
    Melamed J; Schwartz RH; Hirsch SR; Cohen SH
    Ann Allergy; 1994 Jul; 73(1):57-66. PubMed ID: 8030804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
    Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
    Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.